06 November, 2019 - 07 November, 2019

09:00 to 17:30UTC±00:00

IFPMA SE-Asia Ethics & Business Integrity Days

IFPMA SE-Asia Ethics & Business Integrity Days

Bangkok, Hotel The Sukosol, November 6-7, 2019

Following successful Code Capacity Workshops in locations such as Mexico City, Accra, Beijing, Dubai, Johannesburg and Manila, the global association of the research-based pharmaceutical industry (www.ifpma.org) has selected Bangkok to deliver a hands-on training on the recently launched revised Code of Practice and to engage in a broader discussion about the progress and the future of ethics & business integrity in Thailand and South-East Asia as a whole – with regional and international IFPMA experts.

This workshop is free of charge – all time and effort is donated by IFPMA and its member companies and associations.

Workshop capacity is limited and registration confirmation will be on a first-come first-served basis. Once registered, a space will be assigned to you. Therefore, please make sure you can come or let the organizers know so your place can be given to someone on the waiting list.

You can access the registration platform here

November 6 - 09:00 - 17:30

Hands-on Code Capacity Workshop

The workshop has been designed to provide “business case” exposure to participants on day to day topics including:
- How to properly interact with Healthcare Professionals (doctors, nurses, pharmacists etc.) for promotional and medical information sharing
- Increasing the level of ethical conduct of activities in your organization
- Insights on how to set up and run a successful compliance program in your organization
- Interactions with patient organizations
- Activities like commissioning and creation of promotional material and writing and approving copy and artwork.
- Determining promotional methods including professional representation, hospitality to doctors and the use of audio-visual and related communications technology in the organization of international educational events.

The workshop will be based on the new IFPMA Code of Practice (effective Jan 1, 2019) which forms the basis for national codes of practice within Thailand, South-East Asia and worldwide. Participants will receive an update on the Code and the respective interpretation – trainers are keen to engage and exchange with the audience on local implementation.


November 7 - 08:30 - 12:30

Good Governance in Drug Systems

The forum is designed to engage stakeholders to join forces to move ahead. The focus is on how trust in health authorities and healthcare professionals is paramount in implementing a fully efficient healthcare system.
Roundtable participants will address the progress Thailand has been making in raising its standards in the Ethics and Business Integrity space, which is contributing to IFPMA’s goal to create a level playing field in the Thailand market.

The session will be set up as a roundtable discussion with invited key stakeholders as discussants. Other participants are welcome as observers and can engage in the Q&A session.


Varintorn Piyanan

Varintorn Piyanan

Country Head of Ethics & Business Integrity Thailand & Myanmar, Sanofi-Aventis (Thailand) co., Ltd

Anattaya Chotivimut

Anattaya Chotivimut

Compliance Assurance Lead - Asia, Japan, Australia & New Zealand, AstraZeneca (Thailand) Ltd.

Anchalee Anuchitanukul

Anchalee Anuchitanukul

Head of Compliance for Pharma Division and Country Compliance Head - Novartis (Thailand) Ltd.

Sankar Balasubramanian

Sankar Balasubramanian

Ethics and Compliance Officer India, GSK

Vinayak Bindal

Vinayak Bindal

Sub-Regional Compliance Officer, S outh East Asia, Merck Pte. Ltd. Singapore

Saovapa T.  Chutrakul

Saovapa T. Chutrakul

Legal Director & North Asia Cluster Lead, Pfizer (Thailand) Ltd.

Sineenard Deesamut

Sineenard Deesamut

Compliance Manager, Boehringer Ingelheim (Thai) Ltd

Nitika Garg

Nitika Garg

Director - Research, Organisation of Pharmaceutical Producers of India (OPPI)

Sarinthip Jarunsathianchai

Sarinthip Jarunsathianchai

Healthcare Compliance Officer Thailand, Laos, Cambodia & Myanmar, Johnson & Johnson (Thailand) Ltd.

Bussakorn Mahakkanukrauh

Bussakorn Mahakkanukrauh

Medical Affairs Manager, GSK

Orapin Panacharas

Orapin Panacharas

Head of Ethics & Compliance Thailand, Takeda

Areeya Pornwiriyangkura

Areeya Pornwiriyangkura

Associated Director, Local Lead of Ethics & Compliance, Astellas Pharma (Thailand) co., Ltd

Sachin Salian

Sachin Salian

Health Care Compliance Officer Janssen India and South Asia, Johnson & Johnson

Sherita Septiani

Sherita Septiani

Ethics and Compliance Officer Emerging Markets East, GSK

Naparlai Tangsanakun

Naparlai Tangsanakun

Compliance Counsel, Bayer Thai co., Ltd.

Ratanaporn Thangthanakul

Ratanaporn Thangthanakul

HR Development Manager/ Compliance Manager, Eisai (Thailand) Marketing co., Ltd.

Thannicha Vorawatjirapark

Thannicha Vorawatjirapark

Ethics and Compliance Officer, Eli Lilly Asia Inc. Thailand Branch

Holger Diener

Holger Diener

Managing Director, Association of Voluntary Self-Regulation for the Pharmaceutical Industry, Germany and Vice-Chair of the Ethics and Business Integrity Committee of IFPMA

Karen Eryou

Karen Eryou

Head, Ethics and Compliance Programs, UCB Pharma, Belgium Chair Code Capacity Working Group IFPMA

Sofie Melis

Sofie Melis

Head of Ethics & Compliance, IFPMA, Switzerland

Hannes Oswald- Brügel

Hannes Oswald- Brügel

Head Pharma Healthcare Compliance Office, Roche, Switzerland

Christian Roth

Christian Roth

Co-President IPCAA (International Pharmaceutical Congress Advisory Association)

Kiko Tranquilino

Kiko Tranquilino

Consultant on Ethics Matters, Pharmaceutical & Healthcare Association of the Philippines, Inc. (PHAP)

6th Nov 2019

09:00 to 17:30 UTC±00:00

Bangkok, Hotel The Sukosol, November 6-7, 2019


Downloads